null

Phospho-ATF2-T69/T71 Rabbit Polyclonal Antibody (CABP0525)

SKU:
CABP0525
Product Type:
Antibody
Applications:
WB
Reactivity:
Human
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T69/T71 Antibody CABP0525
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T69/T71 Antibody CABP0525
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T69/T71 Antibody CABP0525
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T69/T71 Antibody CABP0525
€419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Phospho-ATF2-T69/T71 Rabbit Polyclonal Antibody (CABP0525)

The Phospho-ATF2 (T69/T71) Polyclonal Antibody (CABP0525) is a valuable tool for researchers studying ATF2, a transcription factor that plays a key role in cellular stress response and regulation of gene expression. This antibody, raised in rabbits, is highly specific for human samples and has been validated for use in Western blot applications. It targets the phosphorylated forms of ATF2 at threonine 69 and threonine 71, allowing for precise detection and analysis in a variety of cell types.ATF2 is involved in numerous cellular processes, including cell growth, apoptosis, and response to DNA damage. Phosphorylation at threonine 69 and threonine 71 is known to regulate ATF2 activity and its ability to transcribe target genes involved in these pathways.

This antibody enables researchers to investigate the role of ATF2 phosphorylation in various biological contexts, providing insights into potential therapeutic targets for conditions such as cancer, neurodegenerative diseases, and metabolic disorders.By using the Phospho-ATF2 (T69/T71) Polyclonal Antibody, researchers can uncover new mechanisms underlying ATF2 function and its impact on cellular signaling pathways. This antibody is a valuable tool for advancing our understanding of ATF2-mediated processes and developing novel strategies for the treatment of diseases influenced by ATF2 activity.